Literature DB >> 28541964

ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOPHTHALMITIS.

Umesh Chandra Behera1, Monica Budhwani, Taraprasad Das, Soumyava Basu, Tapas Ranjan Padhi, Manas Ranjan Barik, Savitri Sharma.   

Abstract

PURPOSE: To study whether immediate pars plana vitrectomy at the time of sampling vitreous for culture alter the visual and structural outcomes in fungal endophthalmitis.
METHODS: Surgical results of 66 consecutive patients with culture-positive fungal endophthalmitis attending a tertiary eye care hospital in eastern India were analyzed. Based on the timing of vitrectomy, they were divided into 2 groups: Group 1-immediate vitrectomy (n = 31) and Group 2-diagnostic vitrectomy alone (n = 35) as the first-line intervention. The demographics, clinical features, and visual and structural outcomes were compared between the groups.
RESULTS: The proportion of postoperative (54.83 vs. 51.42%), traumatic (29.03 vs. 34.28%), and endogenous (16.12 vs. 14.28%) endophthalmitis and clinical signs such as pain (54.83 vs. 60%), lid edema (48.38 vs. 48.57%), conjunctival congestion (87.09 vs. 94.28%), and corneal involvement (87.09 vs. 80%) in Groups 1 and 2, respectively, were comparable. Logarithm of the minimum angle of resolution vision improvement in Group 1 was significant (P = 0.0278) though there was no statistically significant difference in posttreatment vision between the groups (P = 0.322). Phthisis was seen in 25.8% in Group 1 and 25.7% in Group 2 (P = 0.993). Aspergillus species was the most common fungal pathogen isolated. Early vitrectomy plus intravitreal antifungals in a subset of clinically suspected fungal endophthalmitis resulted in statistically significant visual improvement over diagnostic vitrectomy plus intravitreal antifungals (P = 0.013).
CONCLUSION: A strong clinical suspicion that translates into early vitrectomy plus intravitreal antifungal antibiotics leads to favorable visual and structural outcomes. A long wait till microbiological confirmation to institute antifungal therapy may result in poorer outcome.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28541964     DOI: 10.1097/IAE.0000000000001727

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Microbial spectrum and risk factors of endogenous endophthalmitis in a tertiary center of Northern China.

Authors:  Lin-Yang Gan; Jun-Jie Ye; Hui-Ying Zhou; Han-Yi Min; Lin Zheng
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

Review 2.  A Review of Antimicrobial Therapy for Infectious Uveitis of the Posterior Segment.

Authors:  Ahmed B Sallam; Kyle A Kirkland; Richard Barry; Mohamed Kamel Soliman; Tayyeba K Ali; Sue Lightman
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

3.  Vitrectomy for endophthalmitis: 5-year study of outcomes and complications.

Authors:  Guy Simon Negretti; WengOnn Chan; Carlos Pavesio; Mahiul Muhammed Khan Muqit
Journal:  BMJ Open Ophthalmol       Date:  2020-03-24

4.  Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes.

Authors:  Vivek Pravin Dave; Rajeev R Pappuru; Avinash Pathengay; Rajan Gupta; Joveeta Joseph; Savitri Sharma; Taraprasad Das
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 Jan-Feb

5.  A 14-Year Retrospective Analysis of Endogenous Endophthalmitis in a Tertiary Referral Center of Southern Thailand.

Authors:  Patama Bhurayanontachai; Phingphan Klongthanakit
Journal:  J Ophthalmol       Date:  2020-12-15       Impact factor: 1.909

6.  Chronic endogenous fungal endophthalmitis: diagnostic and treatment challenges: A case report.

Authors:  Dian Nadia Abu Talib; Meng Hsien Yong; Rona Asnida Nasaruddin; Jemaima Che-Hamzah; Mae-Lynn Catherine Bastion
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

7.  Understanding the science of fungal endophthalmitis - AIOS 2021 Sengamedu Srinivas Badrinath Endowment Lecture.

Authors:  Taraprasad Das; Joveeta Joseph; Saumya Jakati; Savitri Sharma; Thirumurthy Velpandian; Srikant K Padhy; Vipin A Das; Sisinthy Shivaji; Sameera Nayak; Umesh C Behera; Dilip K Mishra; Jaishree Gandhi; Vivek P Dave; Avinash Pathengay
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

Review 8.  Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments.

Authors:  Alisha Khambati; Robert Emery Wright; Susmita Das; Shirisha Pasula; Alejandro Sepulveda; Francis Hernandez; Mamta Kanwar; Pranatharthi Chandrasekar; Ashok Kumar
Journal:  J Fungi (Basel)       Date:  2022-06-22

9.  Endophthalmitis at a tertiary referral center: Characteristics and treatment outcomes over three decades.

Authors:  Wen-Fei Zhang; Xin-Yu Zhao; Li-Hui Meng; Huan Chen; You-Xin Chen
Journal:  Front Cell Dev Biol       Date:  2022-08-08

Review 10.  The Diagnosis and Treatment of Fungal Endophthalmitis: An Update.

Authors:  Ciprian Danielescu; Horia Tudor Stanca; Raluca-Eugenia Iorga; Diana-Maria Darabus; Vasile Potop
Journal:  Diagnostics (Basel)       Date:  2022-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.